LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 232 filers reported holding LOXO ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.50 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $22,003,000 | -17.9% | 128,800 | -35.8% | 0.02% | +53.3% |
| Q2 2018 | $26,804,000 | +69.2% | 200,500 | +46.0% | 0.02% | -11.8% |
| Q1 2018 | $15,840,000 | -17.0% | 137,300 | -33.7% | 0.02% | -22.7% |
| Q3 2017 | $19,078,000 | +3122.6% | 207,100 | +895.7% | 0.02% | +2100.0% |
| Q4 2015 | $592,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 4,028,920 | $129,409,000 | 30.09% |
| Casdin Capital, LLC | 360,000 | $11,561,000 | 9.55% |
| DAFNA Capital Management LLC | 139,722 | $4,487,000 | 3.94% |
| Opaleye Management Inc. | 125,000 | $4,014,000 | 2.36% |
| Eventide Asset Management | 740,000 | $23,765,000 | 1.55% |
| Crawford Lake Capital Management, LLC | 52,713 | $1,693,000 | 1.22% |
| AWM Investment Company, Inc. | 180,000 | $5,781,000 | 1.13% |
| Orbimed Advisors | 1,728,000 | $55,495,000 | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 423,276 | $13,594,000 | 0.48% |
| EAM Investors, LLC | 111,268 | $3,573,000 | 0.48% |